longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AirSculpt Tech

AIRS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -15.54, within the reasonable range, cheaper than 44.44% of the time in the past 1 years, and the industry ranks 50/74, the industry Median --.

-15.54xP/E
$2.53Stock price
$-0.16Earnings per share
-15.54xP/E
Stock price$2.53Earnings per share$-0.16

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-16.40x
Typical range
-31.26x–-8.68x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GHUSGuardant Health
-52.43x2.92%$23.77B
HIMSUSHims & Hers Health
-49.99x209.86%$7.10B
RDNTUSRadnet
-275.53x128.00%$5.82B
WGSUSGeneDx
-25.46x359.59%$2.71B
NEOUSNeogenomics
-46.78x64.73%$2.43B
AGLUSagilon health
-6.28x93.07%$1.46B
INNVUSInnovage
-573.07x2,301.70%$1.45B
OPKUSOpko Health
-17.71x25.44%$1.29B
CSTLUSCastle Biosciences
-54.84x53.28%$1.06B
LMRIUSLumexa Imaging
-36.45x146.66%$1.01B
GMRSUSGMR Solutions
-8.08x91.45%$610.99M
FLGTUSFulgent Genetics
-7.06x42.64%$595.71M
PREUSPrenetics Global
-8.35x16.63%$392.59M
AONCUSAmerican Oncology Network
----$371.06M
BDSXUSBiodesix
-10.70x42.77%$297.01M
GAMGUSGlobal Asset Management Group, Inc.
-350.92x--$198.07M
AIRSUSAirSculpt Tech
-15.54x33.33%$182.40M
NAKAUSNakamoto
-0.42x102.50%$176.62M
CORBFUSGlobal Cord Blood Corporation
----$127.35M
PARKUSPark Dental Partners
-27.31x--$96.53M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.